NCT02706431

Brief Summary

Oxygenation with high-flow nasal cannula with 100% oxygen has only been evaluated in a limited number of studies. Although data are convincing it is of importance to evaluate this new concept in our department before implementing it into clinical practice. The general purpose of this project is to evaluate a new ventilation strategy during ENT-surgery based on oxygenation with high-flow nasal cannula with 100% oxygen with focus on gas exchange.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2015

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2015

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

December 15, 2015

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 11, 2016

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

December 19, 2017

Status Verified

December 1, 2017

Enrollment Period

7 months

First QC Date

December 15, 2015

Last Update Submit

December 17, 2017

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in arterial carbon dioxide (pCO2)

    From start of anaesthesia to end of apnoea oxygenation or max 30 minutes

  • Change in arterial pH

    From start of anaesthesia to end of apnoea oxygenation or max 30 minutes

  • Change in arterial oxygen tension (pO2)

    From start of anaesthesia to end of apnoea oxygenation or max 30 minutes

Secondary Outcomes (4)

  • Does hyperventilation prior to anaesthesia and apnoea oxygenation cause any difference in pCO2 in the end of the apnea (i.e. at up to 30 minutes) compared to normoventilation?

    In the end of the apnoea period, i.e. at approximately 20 minutes

  • Does hyperventilation prior to anaesthesia and apnoea oxygenation cause any difference in pH in the end of the apnea (i.e. at up to 30 minutes) compared to normoventilation?

    In the end of the apnoea period, i.e. at approximately 20 minutes

  • Does hyperventilation prior to anaesthesia and apnoea oxygenation cause any difference in pO2 in the end of the apnea (i.e. at up to 30 minutes) compared to normoventilation?

    In the end of the apnoea period, i.e. at approximately 20 minutes

  • Does the high oxygen content cause atelectasis measures as change in relation between pCO2 and end tidal carbon dioxide

    Until discharge from the postoperative unit, often max 2 hours

Study Arms (2)

Normoventilation

NO INTERVENTION

The patients will be normoventilated before anesthesia

Hyperventilation

EXPERIMENTAL

Prior to anesthesia, the patients will hyperventilate during 2 mins or until symptoms from the central nervous system (e.g. dizziness).

Procedure: Hyperventilation

Interventions

Hyperventilation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult, \>18 years old
  • ENT-surgery where apnea is of benefit for the surgeon (eg. intraoral or laryngeal surgery) and the anesthesia time is \<40 mins.
  • Capable of understanding the study information and sign the written consent.

You may not qualify if:

  • ASA\>2
  • NYHA \>2
  • BMI \>30
  • Pregnancy
  • Manifest cardiac failure or coronary disease
  • Neuromuscular disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Gustafsson IM, Lodenius A, Tunelli J, Ullman J, Jonsson Fagerlund M. Apnoeic oxygenation in adults under general anaesthesia using Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) - a physiological study. Br J Anaesth. 2017 Apr 1;118(4):610-617. doi: 10.1093/bja/aex036.

MeSH Terms

Conditions

Respiratory Aspiration

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Malin Jonsson Fagerlund, MD, PhD

    Karolinska University Hospital and Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor/Senior Consultant

Study Record Dates

First Submitted

December 15, 2015

First Posted

March 11, 2016

Study Start

December 1, 2015

Primary Completion

June 30, 2016

Study Completion

September 1, 2016

Last Updated

December 19, 2017

Record last verified: 2017-12